Eculizumab in Atypical Hemolytic–Uremic Syndrome

New England Journal of Medicine - United States
doi 10.1056/nejmc1308826
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors

Unknown

Publisher

Massachusetts Medical Society

Related search

Resolution of Ocular Involvement With Systemic Eculizumab Therapy in Atypical Hemolytic-Uremic Syndrome

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2013English

Atypical Hemolytic-Uremic Syndrome

2020English

Transplantation in Atypical Hemolytic Uremic Syndrome

Seminars in Thrombosis and Hemostasis
Cardiovascular MedicineHematologyCardiology
2010English

Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome

Kidney International Reports
Nephrology
2019English

Skin Involvement in Atypical Hemolytic Uremic Syndrome

American Journal of Kidney Diseases
Nephrology
2014English

Monoclonal IgG4/2κ Deposition Following Eculizumab Therapy for Recurrent Atypical Hemolytic Uremic Syndrome in Kidney Transplantation

Kidney Medicine
Internal MedicineNephrology
2019English

The Genetics of Atypical Hemolytic Uremic Syndrome

Medizinische Genetik
Genetics
2018English

Atypical Hemolytic Uremic Syndrome in the Postpartum Period

Proceedings in Obstetrics and Gynecology
2019English

Genetics of Atypical Hemolytic Uremic Syndrome (aHUS)

Seminars in Thrombosis and Hemostasis
Cardiovascular MedicineHematologyCardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy